STRS Ohio’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,474
| Closed | -$805K | – | 2362 |
|
|
2020
Q3 | $805K | Sell |
9,474
-7,632
| -45% | -$386K | ﹤0.01% | 1050 |
|
|
2020
Q2 | $606K | Buy |
17,106
+3,206
| +23% | +$93.7K | ﹤0.01% | 1172 |
|
|
2020
Q1 | $187K | Sell |
13,900
-5,000
| -26% | -$84.1K | ﹤0.01% | 1566 |
|
|
2019
Q4 | $399K | Buy |
18,900
+3,600
| +24% | +$63.5K | ﹤0.01% | 1518 |
|
|
2019
Q3 | $202K | Sell |
15,300
-56,151
| -79% | -$825K | ﹤0.01% | 1639 |
|
|
2019
Q2 | $991K | Sell |
71,451
-1,900
| -3% | -$28.6K | ﹤0.01% | 836 |
|
|
2019
Q1 | $1.41M | Sell |
73,351
-3,300
| -4% | -$53.2K | 0.01% | 724 |
|
|
2018
Q4 | $1.09M | Buy |
76,651
+2,200
| +3% | +$43.7K | 0.01% | 757 |
|
|
2018
Q3 | $1.55M | Buy |
74,451
+9,900
| +15% | +$234K | 0.01% | 720 |
|
|
2018
Q2 | $1.53M | Buy |
+64,551
| New | +$1.3M | 0.01% | 731 |
|
|
2014
Q2 | – | Sell |
-27,300
| Closed | -$115K | – | 1796 |
|
|
2014
Q1 | $115K | Hold |
27,300
| – | – | ﹤0.01% | 1531 |
|
|
2013
Q4 | $126K | Sell |
27,300
-3,200
| -10% | -$14.2K | ﹤0.01% | 1527 |
|
|
2013
Q3 | $189K | Buy |
+30,500
| New | +$176K | ﹤0.01% | 1509 |
|
STRS Ohio's IMMU Position: Q4 2020 in Review
STRS Ohio sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 9,474 shares — an estimated $805K sold.
STRS Ohio first reported a position in IMMU in Q3 2013 and held it in 13 quarters. The position peaked at $1.55M in Q3 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- STRS Ohio reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- STRS Ohio sold 9,474 Immunomedics Inc shares in Q4 2020, an estimated $805K.
- STRS Ohio first reported a position in Immunomedics Inc in Q3 2013 and held it in 13 quarters.
- STRS Ohio's Immunomedics Inc position peaked at $1.55M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.